MiR-92a Inhibits the Progress of Osteosarcoma Cells and Increases the Cisplatin Sensitivity by Targeting Notch1

Figure 3

MiR-92a overexpression and Notch1 knock down enhanced and suppressed, respectively, the susceptibility of osteosarcoma cells to cisplatin. (a, b) MTT was used to detect the cell viability of OG63 and HOS cells treated by cisplatin of different concentrations. (c, d) MTT was used to detect the cell viability of OG63 and HOS cells treated by cisplatin of different times. Data represent mean ± SD. P < 0.05; P < 0.01.

(a)

(b)

(c)

(d)